European sunscreen is sunscreen sold under EU rules, where products can use a wider range of UV filters and make stronger UVA claims than U.S. OTC sunscreens, which must stick to FDA-listed active ingredients and limits.
For the full breakdown, see our best European Sunscreen guide.
Buying sunscreen in the U.S. means navigating a short, rigid list of allowed ingredients—and that list just changed for the first time in decades. Understanding that shift, plus how it compares to Europe’s broader filter palette, explains why the same bottle can look so different depending on which side of the Atlantic it’s sold.
What Is European Sunscreen, Exactly?
European sunscreen means sunscreen regulated under European Union rules, not a distinct product type—it describes where and how a formula is approved. The main practical difference for a U.S. audience is regulatory: Europe has long had a wider palette of UV filters, while the U.S. limits over-the-counter marketing to FDA-listed actives and concentrations. That’s why European formulas feel different to shoppers used to American shelves—the ingredients and claims differ, even when both say “broad spectrum.”
How Is European Sunscreen Different From American Sunscreen?
The biggest difference is the filter list. European products commonly use UV filters not historically permitted in U.S. OTC sunscreens—bemotrizinol being the clearest example, which the FDA noted has been used safely in Europe for decades.
A second difference is labeling emphasis: European products often highlight broad-spectrum UVA protection and higher UVA claims than U.S. packaging. Exact EU label specifications aren’t covered in the official U.S. sources here, so treat specific European label language as a general market distinction rather than a fixed rule.
The takeaway: high SPF doesn’t mean the same thing everywhere. FDA monograph ingredients and concentrations control U.S. OTC legality—not the number on the front.
What Changed In The U.S. Rules In 2026?
Two things: the FDA finalized an order adding bemotrizinol, and a separate order removing PABA and trolamine salicylate from the OTC sunscreen monograph.
Once the 2026 final order is in effect, products containing PABA or trolamine salicylate can no longer be marketed under the OTC monograph and can’t be sold without FDA approval. The FDA’s review found risks outweighed benefits for OTC sunscreen use in those two ingredients.
What Does This Mean For A U.S. Shopper?
Check the active ingredients, not the buzzwords. If a formula lists bemotrizinol, it can only be sold in the U.S. if it complies with monograph conditions; otherwise it needs separate FDA authorization.
Permitted U.S. actives and concentration ceilings are set in the monograph:
| Common U.S. Active | Max Concentration |
|---|---|
| Avobenzone | 3% |
| Bemotrizinol (new in 2026) | 6% |
| Homosalate | 15% |
| Octinoxate | 7.5% |
| Octocrylene | 10% |
| Oxybenzone | 6% |
| Zinc oxide | 25% |
Aminobenzoic acid (PABA) and trolamine salicylate are no longer among them.
To compare formulas before buying, our tested European sunscreen roundup walks through specific bottles that lean on the broader EU filter palette.
Two caveats: European-label claims aren’t governed by the U.S. monograph, so a “UVA” badge means different things across the ocean. Second, the 2011 sunscreen final rule applies only to OTC sunscreens marketed without approved applications and containing the listed ingredients; it does not apply to products sold under approved NDAs or ANDAs, which pharmacies and retailers can still carry.
Why Did The U.S. List Stay Short For So Long?
The U.S. treats sunscreen as an OTC drug, not a cosmetic, so every new filter must go through the FDA’s monograph or approval process—which takes years. Europe regulates sunscreens differently, allowing a wider palette to reach shelves faster. The result: bemotrizinol, standard in Europe for decades, only cleared the U.S. process in 2026. The implication is simple—read the active ingredients, check concentrations against the monograph, and treat country-of-origin branding as marketing rather than a guarantee.
FAQs
Is European sunscreen stronger than American sunscreen?
Not automatically. European formulas can use a wider filter palette and often emphasize UVA claims, but U.S. formulas must comply with the FDA monograph. Strength depends on the specific actives and concentrations, not the country of origin.
Can I legally buy European sunscreen in the U.S.?
You can buy sunscreen sold in the U.S., but ingredients must comply with FDA rules. A European formula using a filter not in the U.S. monograph—or above the allowed concentration—can’t be marketed here without FDA authorization.
Is bemotrizinol now allowed in U.S. sunscreen?
Yes.
What ingredients did the FDA remove in 2026?
PABA (aminobenzoic acid) and trolamine salicylate were removed from the monograph. Products containing them can no longer be marketed under the OTC monograph and can’t be sold without FDA approval.
References & Sources
- U.S. Food and Drug Administration. “FDA Expands Sunscreen Options for the First Time in 20 Years” Announces the addition of bemotrizinol and the monograph update.
- U.S. Food and Drug Administration. “Questions and Answers: FDA’s Regulatory Actions Over Counter Sunscreen” Lists OTC000039 and OTC000008-1 and the effective dates.
- U.S. Food and Drug Administration. “Sunscreen: How to Help Protect Your Skin from the Sun” Explains how OTC sunscreens are regulated and how to use them.